Navigation Links
Z Trim Holdings, Inc. Records First Non-GMO Corn Sales

MUNDELEIN, Ill., Feb. 6, 2013 /PRNewswire/ -- Z Trim Holdings, Inc. (OTC Markets: ZTHO – News), a biotechnology company providing value-added ingredients to a variety of industries, today announced that it had recorded its first sales of non-GMO Corn Z Trim. In December of 2012 the Company announced that it had added non-GMO corn Z Trim to its product line.

"Achieving this first sale so soon after announcing the offering reaffirms that there is a large market for this product line," said Z Trim CEO, Steve Cohen . "We can now begin to service the huge European, Asian and Australian markets as well as domestic specialty markets, which will only accept non-GMO corn products."


Z Trim Holdings, Inc. ( is a bio-technology company that owns existing, and has developed new, products and processes to make use of biomass for uses in the food and industrial markets. The Company's food division currently sells a line of products to the food industry that can help food manufacturers reduce their costs and help them solve many production problems. The Company's revolutionary technology provides value-added ingredients across virtually all food industry categories. The Company's all-natural products, among other things, help to reduce fat and calories, add fiber, provide shelf-stability, prevent oil migration, and add binding capacity – all without degrading the taste and texture of the final food products. Perhaps most significantly, Z Trim's products can help extend finished products, and thereby increase its customers' gross margins. The Company's industrial division, opened in 2012, plans to sell eco-friendly ingredients to oil drilling, hydraulic fracturing, petroleum coke, steel/aluminum, paper and other industries. The Company's industrial ingredients are highly functional in applications for adhesives, binders, viscofiers and emulsifiers.

Forward-Looking Statements and Risk Factors

Certain statements in this press release are "forward−looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of Z Trim Holdings to be materially different from any future results, performance or achievements expressed or implied by these forward−looking statements. Other factors, which could materially affect such forward−looking statements, can be found in our filings with the Securities and Exchange Commission at, including risk factors relating to our history of operating losses, that our auditors have expressed substantial doubt regarding our ability to continue as a going concern, the fact that we may dilute existing shareholders through additional stock issuances, and our reliance on our intellectual property. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward−looking statements and are cautioned not to place undue reliance on such forward−looking statements. The forward−looking statements made herein are only made as of the date of this press release and we undertake no obligation to publicly update such forward−looking statements to reflect subsequent events or circumstances.Contacts:Media:

Investor Relations:Angela Strickland

Thomas Wagner (847) 549-6002

Legend Securities,

718-233-2627 Follow Z Trim on LinkedInJohn ColumbiaLegend Securities, Inc.718-233-2677

SOURCE Z Trim Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Z Trim Holdings, Inc. Enters into Joint Development Agreement with Drilling Fluids Company
2. Z Trim Holdings, Inc. adds non-GMO corn products to its product line
3. Organovo Holdings, Inc. Investor Presentation Now Available for On-demand Viewing at
4. Aveka Nutra Processing proudly begins producing products from Z Trim Holdings, Inc.
5. Organovo Holdings, Inc. to Webcast, Live, at on August 2nd
6. Inclinix-PMG Holdings, Inc. Announces Executive Management Changes
7. China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2012 Financial Results on May 15, 2012
8. Innophos Holdings, Inc. Reports First Quarter 2012 Results
9. Bacterin International Holdings, Inc. Schedules Fourth Quarter 2011 Financial Earnings Conference Call
10. Kenrico Announces Records of Patents for 2012 and Financial Targets for 2013
11. ARAMARK Introduces Worlds First Reusable Validated Sterile Goggle That Remains Clear When Irradiated
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... ... maintain healthy metabolism. But unless it is bound to proteins, copper is also ... Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... 2015 --> ... "Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, ... DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) ... market is expected to reach USD 1,918.6 Million by ... CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
Breaking Biology News(10 mins):